16 HOW SUPPLIED/STORAGE AND HANDLING

TRAVATAN Z® (travoprost ophthalmic solution) 0.004% is a sterile, isotonic, buffered, preserved, aqueous solution of travoprost (0.04 mg/mL) supplied in Alcon's oval DROP-TAINER® package system.

TRAVATAN Z® is supplied as a 2.5 mL solution in a 4 mL and a 5 mL solution in a 7.5 mL natural polypropylene dispenser bottle with a natural polypropylene dropper tip and a turquoise polypropylene or high density polyethylene overcap. Tamper evidence is provided with a shrink band around the closure and neck area of the package.

2.5 mL fill           NDC 0065-0260-25 

5 mL fill              NDC 0065-0260-05 

Storage: Store at 2°C to 25°C (36°F-77°F).

Close 

17 PATIENT COUNSELING INFORMATION

Potential for Pigmentation 

Advise the patient about the potential for increased brown pigmentation of the iris, which may be permanent. Inform the patient about the possibility of eyelid skin darkening, which may be reversible after discontinuation of TRAVATAN Z® (travoprost ophthalmic solution) 0.004%.

Potential for Eyelash Changes 

Inform the patient about the possibility of eyelash and vellus hair changes in the treated eye during treatment with TRAVATAN Z®. These changes may result in a disparity between eyes in length, thickness, pigmentation, number of eyelashes or vellus hairs, and/or direction of eyelash growth. Eyelash changes are usually reversible upon discontinuation of treatment.

Handling the Container 

Instruct the patient to avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to avoid contamination of the solution by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

When to Seek Physician Advice 

Advise the patient that if they develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, they should immediately seek their physician's advice concerning the continued use of TRAVATAN Z®.

Use with Contact Lenses 

Contact lenses should be removed prior to instillation of TRAVATAN Z® and may be reinserted 15 minutes following its administration. 

Use with Other Ophthalmic Drugs 

If more than one topical ophthalmic drug is being used, the drugs should be administered at least 5 minutes between applications.

Rx only 

TIMOPTIC* is a registered trademark of Merck & Co., Inc.

Distributed by:

Alcon Laboratories, Inc. 

Fort Worth, Texas 76134

ALCON® 

A Novartis company

© 2006, 2010, 2011, 2013, 2017 Novartis

T2017-96 

PRINCIPAL DISPLAY PANEL

NDC 0065-0260-25

Rx Only 

Travatan Z® 

(travoprost ophthalmic solution) 0.004%

Alcon® 

2.5 mL STERILE